Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Zoetis Inc Cl A (ZTS)

Zoetis Inc Cl A (ZTS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 57,260,668
  • Shares Outstanding, K 476,299
  • Annual Sales, $ 5,825 M
  • Annual Income, $ 1,428 M
  • 60-Month Beta 0.88
  • Price/Sales 9.78
  • Price/Cash Flow 31.34
  • Price/Book 21.46

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate 0.88
  • Number of Estimates 6
  • High Estimate 0.89
  • Low Estimate 0.87
  • Prior Year 0.79
  • Growth Rate Est. (year over year) +11.39%

Price Performance

See More
Period Period Low Period High Performance
1-Month
114.96 +3.99%
on 11/14/19
129.18 -7.45%
on 11/01/19
-3.26 (-2.65%)
since 10/22/19
3-Month
114.96 +3.99%
on 11/14/19
130.20 -8.18%
on 10/15/19
-7.09 (-5.60%)
since 08/22/19
52-Week
78.90 +51.52%
on 12/24/18
130.20 -8.18%
on 10/15/19
+30.87 (+34.81%)
since 11/21/18

Most Recent Stories

More News
Zoetis Acquires ZNLabs, a Nationwide Veterinary Reference Laboratory, to Further Strengthen its Comprehensive Diagnostics Portfolio

Zoetis Inc. (NYSE:ZTS) today announced the acquisition of ZNLabs, a full-service veterinary clinical reference laboratory company with a network of labs across the U.S. This follows Zoetis' recent acquisition...

ZTS : 119.34 (-0.73%)
Relatively Good Performance Detected in Shares of Zoetis Inc in the Pharmaceuticals Industry (ZTS , LLY , MRK , AGN , MYL )

Here are the top 5 stocks in the Pharmaceuticals industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

LLY : 116.26 (+1.32%)
MRK : 85.89 (+0.50%)
ZTS : 119.34 (-0.73%)
Zacks.com featured highlights include: Heico, Microsoft, Zoetis and Cadence Design System

Zacks.com featured highlights include: Heico, Microsoft, Zoetis and Cadence Design System

HEI : 129.13 (-0.54%)
MSFT : 149.26 (-0.15%)
CDNS : 66.89 (-0.43%)
ZTS : 119.34 (-0.73%)
Watch for Zoetis Inc to Potentially Pullback After Gaining 1.40% Yesterday

Zoetis Inc (NYSE:ZTS) traded in a range yesterday that spanned from a low of $117.58 to a high of $119.81. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $117.74...

ZTS : 119.34 (-0.73%)
4 GARP Stocks for a Winning Portfolio

Growth at a reasonable price or GARP strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount.

HEI : 129.13 (-0.54%)
MSFT : 149.26 (-0.15%)
CDNS : 66.89 (-0.43%)
ZTS : 119.34 (-0.73%)
Should First Trust Capital Strength ETF (FTCS) Be on Your Investing Radar?

Style Box ETF report for FTCS

FTCS : 58.82 (-0.08%)
AMT : 210.47 (-1.44%)
IVV : 312.57 (+0.16%)
SPY : 310.81 (+0.17%)
AMGN : 230.06 (+0.98%)
ZTS : 119.34 (-0.73%)
JAZZ or ZTS: Which Is the Better Value Stock Right Now?

JAZZ vs. ZTS: Which Stock Is the Better Value Option?

JAZZ : 146.67 (+2.83%)
ZTS : 119.34 (-0.73%)
Zoetis (ZTS) Beats on Earnings in Q3, Reports In-Line Sales

Zoetis (ZTS) beats earnings estimates, while sales are in line in the third quarter of 2019.

ACOR : 1.92 (+10.98%)
AVEO : 0.62 (+1.64%)
ALKS : 20.69 (+3.04%)
ZTS : 119.34 (-0.73%)
Zoetis (ZTS) Tops Q3 Earnings and Revenue Estimates

Zoetis (ZTS) delivered earnings and revenue surprises of 5.62% and 0.17%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

ZTS : 119.34 (-0.73%)
Zoetis: 3Q Earnings Snapshot

PARSIPPANY, N.J. (AP) _ Zoetis Inc. (ZTS) on Thursday reported third-quarter earnings of $433 million.

ZTS : 119.34 (-0.73%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakening short term outlook on maintaining the current direction.

The current trending strength of the market is Weak.

See More Share

Trade ZTS with:

Business Summary

Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services.

See More

Key Turning Points

2nd Resistance Point 121.91
1st Resistance Point 121.06
Last Price 119.34
1st Support Level 119.38
2nd Support Level 118.54

See More

52-Week High 130.20
Last Price 119.34
Fibonacci 61.8% 110.60
Fibonacci 50% 104.55
Fibonacci 38.2% 98.50
52-Week Low 78.90

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar